INTRODUCTION AND OBJECTIVES: Clinical Gleason score 8/Grade Group 4 (cGG4) prostate cancer (PCa) is characterized as high-risk and thereby, for men treated with radiation (RT), entails longterm androgen deprivation therapy (ADT). However, the potential for downgrading in Gleason score exists, and therefore characterization of risk factors for pathologic downgrading of cGG4 can potentially allow patients to be managed with intermediate risk RT/ADT protocols. Herein, we evaluate the incidence and predictors of downgrading among patients with cGG4 by assessing pathologic outcomes at radical prostatectomy (RP).
METHODS: We reviewed our institutional prostatectomy registry to identify patients with cGG4 PCa who underwent RP between 2006-2017. Downgrading was defined as pathologic GG3 or less. Multivariable logistic regression assessed factors associated with downgrading. Survival was assessed using the Kaplan-Meier method.
RESULTS: Of 244 patients, 118 (48%) were downgraded, of whom 73 were pGG3, 42 pGG2, and 3 pGG1. Patients with downgrading had similar age and clinical T-stage (p>0.05), but lower mean PSA (8.3 vs 11.6 ng/mL, p[0.048). Patients with downgrading were more likely to have a lower percent GG4 cores in the total (23% vs 37%) and positive (58% vs 80%) cores than those without downgrading (both p<0.001). Increasing number of cores of GG4 was associated with decreased odds of downgrading (OR 0.76, p<0.001 ). On multivariable analysis (Table 1) , a higher number of GG1-GG3 cores was associated with increased odds of downgrading (OR 1.17), while a higher number of GG4 cores was associated with decreased odds of downgrading (OR 0.85, both p<0.05). Median follow-up among survivors was 5.8 years ), during which time 20 patients died, of whom 11 died of PCa. Patients with downgrading had significantly improved 10-year biochemical recurrence-free (66% vs 29%), systemic progression-free (75% vs 51%), PCa-specific (97% vs 84%), and overall survival (86% vs 74%) (all p<0.05).
CONCLUSIONS: Nearly half of the patients with GG4 on core biopsy experience downgrading at RP. Pending validation, this information may be useful when counseling patients with cGG4 and risk factors for downgrading, especially when considering duration of ADT for those electing radiation. 
INTRODUCTION AND OBJECTIVES:
The main challenge in robot assisted radical prostatectomy (RARP) is to achieve an optimal oncological result without compromising the functional outcomes by using a nerve-sparing approach. Extracapsular tumor extension (ECE) makes a nerve sparing RARP oncological unsafe. Therefore, it is important to know the likelihood of side-specific ECE. Since prostate MRI underestimates the presence of ECE, we determined the potential additional value of a nomogram, including oncological as well as MRI findings, to predict side-specific ECE.
METHODS: Patients with prostate cancer who underwent RARP in 2014-2017 in two Dutch teaching hospitals were included for analysis. Predictors included in the multivariable logistic regression model were: Epstein grading, PSA density, presence of side specific ECE on MRI, percentage of biopsies containing cancer per side, and side-specific suspect findings on digital rectal examination (cT2 or cT3 vs. cT1). Primary outcome was side specific ECE established by experienced uropathologists during PA evaluation of the prostate specimen. Diagnostic accuracy of our prediction model was compared with results of prostate MRI alone. In our model, a calculated probability of >20% for presence of side-specific ECE was used as threshold to define a positive test result (ECE present).
RESULTS: A total of 932 patients were included for analysis. The developed model was superior to prostate MRI alone regarding sensitivity of ECE presence, negative predictive value (ECE absence) and area under the curve (Table) . Compared with MRI alone, our prediction model identified side specific ECE in more than a quarter of the patients (sensitivity 79% vs. 53% for left-sided ECE and 81% vs. 46% for rightsided ECE). Moreover, the negative predictive value (NPV) was 92%, using the model with a cut-off of >20%. Thus, nerve-sparing can be done safely in patients with a probability of ECE <20% (Table) . CONCLUSIONS: The nomogram is able to detect more cases of ECE preoperatively in comparison to MRI alone. Combined with its high NPV, it is a useful tool in the preoperative planning of a side specific safe nerve sparing radical prostatectomy.
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